Literature DB >> 3953270

Abnormal pancreatic electrolyte secretion in cystic fibrosis. Reliability as a diagnostic marker.

G P Davidson, C P Kirubakaran, G Ratcliffe, D M Cooper, T A Robb.   

Abstract

We performed pancreatic function tests on sixty-five cystic fibrosis (CF), and eleven control children. The technique used continuous IV infusion of cholecystokinin and secretin, with duodenal juice collection over a 90 min period, and was made quantitative by continuous duodenal infusion and distal collection of an unabsorbable marker (bromosulphthalein). Some CF patients had near normal pancreatic enzyme outputs, some had impaired but measurable levels, but most (79%) had almost absent trypsin secretion. CF children with better pancreatic function, were younger and more likely to be male. All controls showed a large increase in bicarbonate concentration and secretion rate per kilogram body weight during the test, but most children with CF (96.5%) did not. Because two of our CF patients had water and bicarbonate secretion within the control range, this finding does not exclude the diagnosis of CF. Sodium, potassium and chloride ion secretion in CF patients was lower than controls but overlap occurred. We found a linear correlation between acinar and tubular secretion in CF patients which indicates that there is probably not a primary genetic defect in pancreatic bicarbonate secretion in CF.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3953270     DOI: 10.1111/j.1651-2227.1986.tb10171.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  2 in total

1.  Pharmacokinetics and tolerability of oral sildenafil in adults with cystic fibrosis lung disease.

Authors:  J L Taylor-Cousar; C Wiley; L A Felton; C St Clair; M Jones; D Curran-Everett; K Poch; D P Nichols; G M Solomon; M T Saavedra; F J Accurso; J A Nick
Journal:  J Cyst Fibros       Date:  2014-11-13       Impact factor: 5.482

2.  Relationships between essential fatty acid levels, pulmonary function and fat absorption in pre-adolescent cystic fibrosis children with good clinical scores.

Authors:  G N Thompson
Journal:  Eur J Pediatr       Date:  1989-01       Impact factor: 3.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.